What is the Impact Factor of Cellular Reprogramming?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Cellular Reprogramming is 2.70, ranking in quartile Q3 of Web of Science (SCIE).

Is Cellular Reprogramming indexed in Web of Science or Scopus?

Yes, Cellular Reprogramming is indexed in Web of Science (SCIE, Q3 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.553 (Q2) and an H-index of 67.

Who publishes Cellular Reprogramming and what is the Article Processing Charge (APC)?

Cellular Reprogramming is published by Mary Ann Liebert Inc.. The estimated Article Processing Charge (APC) is approximately $2,834 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Cellular Reprogramming?

The official ISO-4 abbreviation of Cellular Reprogramming is "CELL. REPROGRAMMING" with common acronym "cellreprogramming". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q3Scopus Q2SCImago #10,718Hybrid

Cellular Reprogramming

Acronym:cellreprogramming

•

Abbreviation (ISO):CELL. REPROGRAMMING

•

Identifier (ISSN):2152-4971(Print)/2152-4998(Online)

•

Publisher:Mary Ann Liebert Inc.

Official Website Submission Portal Compare

Clarivate IF (2026)

2.7↑ +1

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2019–2026)

Clarivate IF trend for Cellular Reprogramming

WoS Q3

Annual Impact Factor Metric

Current (2026):2.7

Scopus SJR & RankScopus Q2

0.553

#10,718

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

67 papers with at least that number of citations each

WoS: SCIE / JCRQ3

Self-Citation Rate0%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

29articles/year

7.41% Gold OA•70% Original Research

Aims & Scope

Cellular Reprogramming is the premier journal dedicated to providing new insights on the etiology, development, and potential treatment of various diseases through reprogramming cellular mechanisms. The Journal delivers information on cutting-edge techniques and the latest high-quality research and discoveries that are transforming biomedical research. Cellular Reprogramming coverage includes: Somatic cell nuclear transfer and reprogramming in early embryos Embryonic stem cells Nuclear transfer stem cells (stem cells derived from nuclear transfer embryos) Generation of induced pluripotent stem (iPS) cells and/or potential for cell-based therapies Epigenetics Adult stem cells and pluripotency.

Topics Covered (Recognized by AI)

BiologyGeneticsChemistryBiochemistryCell BiologyMedicineStem CellsMolecular BiologyFisheriesInternal MedicinePathologyImmunology

Primary Research Areas

Cell & Tissue Engineering Biotechnology & Applied Microbiology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Rank112/180

IndexSCIE

JCRSCIE2026

CELL & TISSUE ENGINEERING

Rank24/32

IndexSCIE

JCRSCIE2026

GENETICS & HEREDITY

Rank92/192

IndexSCIE

JCISCIE2026

BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Rank148/180

IndexSCIE

JCISCIE2026

CELL & TISSUE ENGINEERING

Rank29/32

IndexSCIE

JCISCIE2026

GENETICS & HEREDITY

Rank157/192

IndexSCIE

Category	Index	Rank	Quartile
BIOTECHNOLOGY & APPLIED MICROBIOLOGY	JCRSCIE	112/180	Q3
CELL & TISSUE ENGINEERING	JCRSCIE	24/32	Q3
GENETICS & HEREDITY	JCRSCIE	92/192	Q2
BIOTECHNOLOGY & APPLIED MICROBIOLOGY	JCISCIE	148/180	Q4
CELL & TISSUE ENGINEERING	JCISCIE	29/32	Q4
GENETICS & HEREDITY	JCISCIE	157/192	Q4

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF2.7

Articles / Year10

Total Citations1

2025

IF1.7

Articles / Year29

Total Citations15

2024

IF1.2

Articles / Year29

Total Citations113

2023

IF1.6

Articles / Year41

Total Citations182

2022

IF2.257

Articles / Year40

Total Citations214

Year	Impact Factor	Articles / Year	Total Citations
2026	2.7	10	1
2025	1.7	29	15
2024	1.2	29	113
2023	1.6	41	182
2022	2.257	40	214
2021	1.987	38	192
2020	1.453	37	338
2019	1.43	35	423
2018	—	45	772
2017	—	43	646
2016	—	43	574
2015	—	46	746

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #10,718Scopus Q2SCImago Profile

Scopus Coverage:2010-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular Biology

Scopus Citation Rank (SJR)Q2

0.553

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

1.76

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$2,834 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations163

3-Year Documents101

Citable Documents87

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate48.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

BiotechnologyQ2

Developmental BiologyQ3

Cell BiologyQ4

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

4区CELL & TISSUE ENGINEERING

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Cellular Reprogramming (acronym: cellreprogramming, abbr: CELL. REPROGRAMMING, ISSN: 2152-4971) is a peer-reviewed international scholarly journal in the field of CELL & TISSUE ENGINEERING, published by Mary Ann Liebert Inc. in United States since 2010. The periodical holds a Journal Impact Factor (JIF) of 2.70, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.553 (Q2), an H-index of 67.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 29 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,834 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.